Comment on: "Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma".
作者信息
Zheng Yangyang, Song Jinghai
机构信息
From the Department of General Surgery, Department of Hepato-bilio-pancreatic Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
出版信息
Ann Surg Open. 2023 Jan 30;4(1):e248. doi: 10.1097/AS9.0000000000000248. eCollection 2023 Mar.
Abstract
摘要
相似文献
1
Comment on: "Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma".对《重新评估胰十二指肠切除术治疗胰腺导管腺癌时检查淋巴结的最佳数量》的评论
Ann Surg Open. 2023 Jan 30;4(1):e248. doi: 10.1097/AS9.0000000000000248. eCollection 2023 Mar.
2
The number of lymph nodes identified in a simple pancreatoduodenectomy specimen: comparison of conventional vs orange-peeling approach in pathologic assessment.在单纯胰十二指肠切除标本中识别出的淋巴结数量：病理评估中传统方法与“橘皮样”方法的比较
Mod Pathol. 2009 Jan;22(1):107-12. doi: 10.1038/modpathol.2008.167. Epub 2008 Sep 26.
3
Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma.重新评估胰腺导管腺癌胰十二指肠切除术中检查淋巴结的最佳数量
Ann Surg. 2022 Nov 1;276(5):e518-e526. doi: 10.1097/SLA.0000000000004552. Epub 2020 Nov 9.
4
Lymph node ratio versus number of affected lymph nodes as predictors of survival for resected pancreatic adenocarcinoma.淋巴结比率与受影响的淋巴结数量作为可切除胰腺腺癌生存的预测指标。
World J Surg. 2010 Apr;34(4):768-75. doi: 10.1007/s00268-009-0336-4.
5
A systematic review of the prognostic value of lymph node ratio, number of positive nodes and total nodes examined in pancreatic ductal adenocarcinoma.胰腺导管腺癌中淋巴结比率、阳性淋巴结数量及检查的总淋巴结数量预后价值的系统评价。
Ann R Coll Surg Engl. 2017 Feb;99(2):101-106. doi: 10.1308/rcsann.2016.0340. Epub 2016 Nov 21.
6
Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.胰腺腺癌的淋巴结转移模式和预后：直接淋巴结侵犯的生存情况与淋巴结阴性疾病相似。
Am J Surg Pathol. 2011 Feb;35(2):228-34. doi: 10.1097/PAS.0b013e318206c37a.
7
Original study: The rescue staging for pancreatic ductal adenocarcinoma with inadequate examined lymph nodes.原始研究：胰腺导管腺癌伴检查不足的淋巴结挽救分期。
Pancreatology. 2021 Jun;21(4):724-730. doi: 10.1016/j.pan.2021.02.010. Epub 2021 Feb 18.
8
Does direct invasion of peripancreatic lymph nodes impact survival in patients with pancreatic ductal adenocarcinoma? A retrospective dual-center study.胰腺周围淋巴结的直接侵犯是否会影响胰腺导管腺癌患者的生存？一项回顾性双中心研究。
Pancreatology. 2021 Aug;21(5):884-891. doi: 10.1016/j.pan.2021.03.008. Epub 2021 Mar 19.
9
Minimally invasive versus open pancreatoduodenectomy for pancreatic ductal adenocarcinoma: Individual patient data meta-analysis of randomized trials.微创与开腹胰十二指肠切除术治疗胰导管腺癌的比较：随机试验的个体患者数据分析荟萃分析。
Eur J Surg Oncol. 2023 Aug;49(8):1351-1361. doi: 10.1016/j.ejso.2023.03.227. Epub 2023 Apr 7.
10
Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis.淋巴结比率在胰腺导管腺癌中的作用。对患者分层和预后的影响。
J Surg Oncol. 2011 Nov 1;104(6):629-33. doi: 10.1002/jso.22013. Epub 2011 Jun 28.
本文引用的文献
1
Role of Node Dissection in Pancreatic Tumor Resection.淋巴结清扫在胰腺肿瘤切除术中的作用。
Ann Surg Oncol. 2021 Apr;28(4):2374-2381. doi: 10.1245/s10434-020-09394-6. Epub 2021 Jan 3.
2
Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma.重新评估胰腺导管腺癌胰十二指肠切除术中检查淋巴结的最佳数量
Ann Surg. 2022 Nov 1;276(5):e518-e526. doi: 10.1097/SLA.0000000000004552. Epub 2020 Nov 9.
3
Determining the optimal number of examined lymph nodes for accurate staging of pancreatic cancer: An analysis using the nodal staging score model.确定用于准确分期胰腺癌的最佳检查淋巴结数量：使用淋巴结分期评分模型的分析。
Eur J Surg Oncol. 2019 Jun;45(6):1069-1076. doi: 10.1016/j.ejso.2019.01.018. Epub 2019 Jan 18.
4
Assessing the adequacy of lymph node yield for different tumor stages of colon cancer by nodal staging scores.通过淋巴结分期评分评估不同结肠癌肿瘤分期的淋巴结检出量是否充足。
BMC Cancer. 2017 Jul 25;17(1):498. doi: 10.1186/s12885-017-3491-2.
5
How Many Lymph Nodes Are Enough? Assessing the Adequacy of Lymph Node Yield for Papillary Thyroid Cancer.多少个淋巴结才算足够？评估甲状腺乳头状癌淋巴结切除量的充足性
J Clin Oncol. 2016 Oct 1;34(28):3434-9. doi: 10.1200/JCO.2016.67.6437. Epub 2016 Aug 15.
6
Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM.胰腺癌的大小重要吗？：重新评估肿瘤大小作为TNM之外的预后预测指标。
Ann Surg. 2017 Jul;266(1):142-148. doi: 10.1097/SLA.0000000000001837.
Zotero 插件